News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Inverseon Asthma Drug May Compliment LABAs



2/24/2010 10:15:21 AM

SAN FRANCISCO--(BUSINESS WIRE)--Inverseon, Inc. (http://www.inverseon.com) comments on Long Acting Beta-Agonists (LABAs) and INV102CR.

Read at BioSpace.com


comments powered by Disqus
Inverseon
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES